Parkinson's disease (PD) is a neurodegenerative disorder that affects millions of people
worldwide. Two hallmarks of PD are the accumulation of alpha‐synuclein and the loss of …

Diagnosis of neurological and psychiatric conditions associated with disturbances of
dopaminergic functioning can be challenging, especially in the early stages, and may be …

Parkinson's disease (PD) is associated with an abnormal pattern of regional brain function.
The expression of this PD-related covariance pattern (PDRP) has been used to assess …

Positron emission tomography (PET) and single photon emission computed tomography
(SPECT) can measure striatal dopamine (DA) terminal function in vivo as reflected by DA …

A lack of standardized evaluation procedures for dopamine transporter (DAT) SPECT
investigations impairs both intra-and interindividual comparisons as well as multicenter trials …

Recent lines of research suggest that, in addition to hypothalamic sites, the striatum
dopaminergic system may be a target for regulating homeostasis that may be represented …

Brain oxytocin and dopamine systems interact to modulate social cognitive behavior.
Whether the interactions are modulated by oxytocin receptor (OXTR) gene variations …

The oxytocin (OXT) and dopamine systems synergistically facilitate striatal reactivity.
Abnormal striatal activation has repeatedly been observed in patients with bipolar disorder …

BACKGROUND: Bupropion is thought to exert its antidepressive effect by blocking the
dopamine transporter (DAT). The purpose of this study was to evaluate the DAT activity in …

Objective: The goal of the current investigation was to explore whether salivary DJ-1 could
be a potential biomarker for monitoring disease progression in Parkinson's disease (PD) by …